(Q40401032)

20 September 2017

1 reference

title

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy (English)

1 reference

20 September 2017

0 references

1 reference

Fan TP

1

1 reference

PubMed ID

7539171

20 September 2017

Jaggar R

series ordinal

2

1 reference

PubMed ID

7539171

20 September 2017

Bicknell R

series ordinal

3

1 reference

20 September 2017

1 February 1995

1 reference

Trends in Pharmacological Sciences

20 September 2017

1 reference

20 September 2017

16

1 reference

20 September 2017

57-66

1 reference

20 September 2017

2

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Angiogenesis inhibition: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Application of basic fibroblast growth factor may reverse diabetic wound healing impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Cardioprotective actions of transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Transforming growth factor-beta 1 reduces infarct size after experimental cerebral ischemia in a rabbit model.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Angiosuppressive therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Analysis of experimental antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Angiogenesis inhibition suppresses collagen arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Regulation of NANC neural bronchoconstriction in vivo in the guinea-pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

A pilot study of suramin in the treatment of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Protamine is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Identification of an Inhibitor of Neovascularization from Cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Specific inhibition of endothelial cell proliferation by thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

[Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Angiogenic activity of enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

The human blood platelet: a cellular model to study the degradation of thymidine and its inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Vascular permeability factor (VPF, VEGF) in tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

The Combination of a Bacterial Polysaccharide and Tamoxifen Inhibits Angiogenesis and Tumour Growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988979-8

7 January 2021

10.1016/S0165-6147(00)88979-8

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7539171